DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,424,724 | +3.2% | 21,865 | -0.2% | 1.80% | +9.8% |
Q2 2023 | $5,256,000 | -6.2% | 21,900 | -1.5% | 1.64% | -8.4% |
Q1 2023 | $5,601,596 | -5.3% | 22,225 | -0.2% | 1.78% | -8.5% |
Q4 2022 | $5,913,297 | +0.0% | 22,279 | -2.7% | 1.95% | -5.8% |
Q3 2022 | $5,911,000 | +2.0% | 22,886 | +0.1% | 2.07% | +9.9% |
Q2 2022 | $5,794,000 | -12.7% | 22,855 | +1.0% | 1.88% | -1.7% |
Q1 2022 | $6,636,000 | -13.6% | 22,624 | -3.1% | 1.92% | -12.1% |
Q4 2021 | $7,678,000 | +8.6% | 23,336 | +0.5% | 2.18% | -0.6% |
Q3 2021 | $7,071,000 | +8.6% | 23,227 | -4.2% | 2.19% | +11.2% |
Q2 2021 | $6,509,000 | +17.7% | 24,254 | -1.3% | 1.97% | +12.2% |
Q1 2021 | $5,529,000 | +1.5% | 24,562 | +0.2% | 1.76% | -7.6% |
Q4 2020 | $5,446,000 | -0.3% | 24,517 | -3.4% | 1.90% | -5.0% |
Q3 2020 | $5,465,000 | +19.3% | 25,383 | -2.0% | 2.00% | +14.2% |
Q2 2020 | $4,579,000 | +33.4% | 25,894 | +4.4% | 1.75% | +14.3% |
Q1 2020 | $3,433,000 | -6.5% | 24,801 | +3.6% | 1.54% | +10.6% |
Q4 2019 | $3,673,000 | +5.9% | 23,930 | -0.4% | 1.39% | -9.2% |
Q3 2019 | $3,470,000 | -1.2% | 24,021 | -2.3% | 1.53% | +5.7% |
Q2 2019 | $3,513,000 | +3.3% | 24,582 | -4.6% | 1.45% | +0.7% |
Q1 2019 | $3,402,000 | +27.0% | 25,766 | -0.8% | 1.44% | +17.8% |
Q4 2018 | $2,678,000 | -6.2% | 25,976 | -1.1% | 1.22% | +6.6% |
Q3 2018 | $2,854,000 | +13.4% | 26,270 | +3.0% | 1.14% | +6.4% |
Q2 2018 | $2,517,000 | -0.4% | 25,505 | -1.1% | 1.08% | -0.9% |
Q1 2018 | $2,526,000 | +4.1% | 25,798 | -1.3% | 1.09% | +9.7% |
Q4 2017 | $2,427,000 | +5.9% | 26,143 | -3.7% | 0.99% | +10.6% |
Q3 2017 | $2,292,000 | 0.0% | 27,156 | 0.0% | 0.90% | 0.0% |
Q2 2017 | $2,292,000 | -8.5% | 27,156 | -7.3% | 0.90% | -9.4% |
Q1 2017 | $2,506,000 | +6.3% | 29,295 | -3.3% | 0.99% | +4.8% |
Q4 2016 | $2,358,000 | -17.5% | 30,301 | -16.9% | 0.94% | -18.3% |
Q3 2016 | $2,858,000 | -23.2% | 36,459 | -1.0% | 1.15% | -23.1% |
Q2 2016 | $3,720,000 | +4.3% | 36,831 | -2.0% | 1.50% | +4.0% |
Q1 2016 | $3,565,000 | -1.1% | 37,589 | -3.1% | 1.44% | -2.6% |
Q4 2015 | $3,604,000 | +9.0% | 38,801 | +0.0% | 1.48% | +6.4% |
Q3 2015 | $3,305,000 | +4.2% | 38,791 | +4.7% | 1.39% | +8.3% |
Q2 2015 | $3,171,000 | +2.4% | 37,046 | +1.6% | 1.28% | +2.2% |
Q1 2015 | $3,096,000 | -0.7% | 36,476 | +0.3% | 1.26% | -1.3% |
Q4 2014 | $3,118,000 | +8.9% | 36,370 | -3.5% | 1.27% | +6.0% |
Q3 2014 | $2,864,000 | -0.7% | 37,690 | +2.9% | 1.20% | -0.1% |
Q2 2014 | $2,884,000 | +6.1% | 36,645 | +1.1% | 1.20% | +1.8% |
Q1 2014 | $2,719,000 | -3.3% | 36,251 | -0.5% | 1.18% | -3.0% |
Q4 2013 | $2,813,000 | +10.0% | 36,431 | -1.3% | 1.22% | +7.8% |
Q3 2013 | $2,557,000 | +9.7% | 36,901 | +0.2% | 1.13% | +9.4% |
Q2 2013 | $2,331,000 | – | 36,830 | – | 1.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |